Skip to main content
Erschienen in:

07.05.2018 | Original Paper

Comparison of pain after subepithelial versus conventional accelerated corneal collagen cross-linking for keratoconus

verfasst von: Shaowei Li, Huatao Xie, Man Xu, Meiyan Li, Chang Liu, Jingliang He, Tian Han, Xingtao Zhou

Erschienen in: International Ophthalmology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the postoperative pain and epithelial healing time in conventional and subepithelial accelerated corneal collagen cross-linking (CXL) for progressive keratoconus.

Methods

The medical records of 27 consecutive patients who underwent accelerated CXL for progressive keratoconus were retrospectively reviewed. Patients were divided into two groups: the conventional (n = 16) and the subepithelial accelerated CXL group (n = 11). Corneal epithelial layers with a diameter of 8.5 mm in central corneas were removed in the conventional group, while epithelial flaps with the same diameter were prepared in the subepithelial group before accelerated CXL procedures. Postoperative pain and epithelial healing time were evaluated within 1 week.

Results

No complications developed in the subepithelial group, whereas peripheral corneal sterile infiltrate was observed in three eyes in the conventional group, which disappeared after treated with steroids for a week. The pain of patients in subepithelial group was significantly slighter than those in conventional group, with a significant difference in pain scoring 0, 1, 2 and 3 days postoperatively (P = 0.002, P = 0.001, P = 0.001, P = 0.001, respectively). Different from the fact that patients in subepithelial group had epithelium after operation, the healing time for epithelium in conventional group was 3–6 days, with an average of 4.64 ± 0.59 days.

Conclusions

Subepithelial accelerated CXL significantly improved postoperative pain as well as reduced the epithelial healing time for the treatment of keratoconus.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Jhanji V, Sharma N, Vajpayee RB (2011) Management of keratoconus: current scenario. Br J Ophthalmol 95:1044–1050CrossRefPubMed Jhanji V, Sharma N, Vajpayee RB (2011) Management of keratoconus: current scenario. Br J Ophthalmol 95:1044–1050CrossRefPubMed
3.
Zurück zum Zitat Kennedy RH, Bourne WM, Dyer JA (1986) A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 101:267–273CrossRefPubMed Kennedy RH, Bourne WM, Dyer JA (1986) A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 101:267–273CrossRefPubMed
4.
Zurück zum Zitat Spoerl E, Huhle M, Seiler T (1998) Induction of cross-links in corneal tissue. Exp Eye Res 66:97–103CrossRefPubMed Spoerl E, Huhle M, Seiler T (1998) Induction of cross-links in corneal tissue. Exp Eye Res 66:97–103CrossRefPubMed
5.
Zurück zum Zitat Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620–627CrossRefPubMed Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620–627CrossRefPubMed
6.
Zurück zum Zitat Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrosio R Jr., Guell JL, Malecaze F, Nishida K, Sangwan VS, Group of Panelists for the Global Delphi Panel of K, Ectatic D (2015) Global consensus on keratoconus and ectatic diseases. Cornea 34:359–369CrossRefPubMed Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrosio R Jr., Guell JL, Malecaze F, Nishida K, Sangwan VS, Group of Panelists for the Global Delphi Panel of K, Ectatic D (2015) Global consensus on keratoconus and ectatic diseases. Cornea 34:359–369CrossRefPubMed
7.
Zurück zum Zitat Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356–360CrossRefPubMed Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356–360CrossRefPubMed
8.
Zurück zum Zitat Ghanem VC, Ghanem RC, de Oliveira R (2013) Postoperative pain after corneal collagen cross-linking. Cornea 32:20–24CrossRefPubMed Ghanem VC, Ghanem RC, de Oliveira R (2013) Postoperative pain after corneal collagen cross-linking. Cornea 32:20–24CrossRefPubMed
9.
Zurück zum Zitat Koller T, Mrochen M, Seiler T (2009) Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 35:1358–1362CrossRefPubMed Koller T, Mrochen M, Seiler T (2009) Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 35:1358–1362CrossRefPubMed
11.
Zurück zum Zitat Leccisotti A, Islam T (2010) Transepithelial corneal collagen cross-linking in keratoconus. J Refract Surg 26:942–948CrossRefPubMed Leccisotti A, Islam T (2010) Transepithelial corneal collagen cross-linking in keratoconus. J Refract Surg 26:942–948CrossRefPubMed
12.
Zurück zum Zitat Filippello M, Stagni E, O’Brart D (2012) Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg 38:283–291CrossRefPubMed Filippello M, Stagni E, O’Brart D (2012) Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg 38:283–291CrossRefPubMed
13.
Zurück zum Zitat Caporossi A, Mazzotta C, Paradiso AL, Baiocchi S, Marigliani D, Caporossi T (2013) Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg 39:1157–1163CrossRefPubMed Caporossi A, Mazzotta C, Paradiso AL, Baiocchi S, Marigliani D, Caporossi T (2013) Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg 39:1157–1163CrossRefPubMed
14.
Zurück zum Zitat De Bernardo M, Capasso L, Tortori A, Lanza M, Caliendo L, Rosa N (2014) Trans epithelial corneal collagen crosslinking for progressive keratoconus: 6 months follow up. Contact Lens Anterior Eye J Br Contact Lens Assoc 37:438–441CrossRef De Bernardo M, Capasso L, Tortori A, Lanza M, Caliendo L, Rosa N (2014) Trans epithelial corneal collagen crosslinking for progressive keratoconus: 6 months follow up. Contact Lens Anterior Eye J Br Contact Lens Assoc 37:438–441CrossRef
15.
Zurück zum Zitat Soeters N, Wisse RP, Godefrooij DA, Imhof SM, Tahzib NG (2015) Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial. Am J Ophthalmol 159(821–828):e823 Soeters N, Wisse RP, Godefrooij DA, Imhof SM, Tahzib NG (2015) Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial. Am J Ophthalmol 159(821–828):e823
16.
Zurück zum Zitat Al Fayez MF, Alfayez S, Alfayez Y (2015) Transepithelial versus epithelium-off corneal collagen cross-linking for progressive keratoconus: a prospective randomized controlled trial. Cornea 34(Suppl 10):S53–S56CrossRefPubMed Al Fayez MF, Alfayez S, Alfayez Y (2015) Transepithelial versus epithelium-off corneal collagen cross-linking for progressive keratoconus: a prospective randomized controlled trial. Cornea 34(Suppl 10):S53–S56CrossRefPubMed
17.
Zurück zum Zitat Ambrosio R Jr, Wilson S (2003) LASIK vs LASEK vs PRK: advantages and indications. Semin Ophthalmol 18:2–10CrossRefPubMed Ambrosio R Jr, Wilson S (2003) LASIK vs LASEK vs PRK: advantages and indications. Semin Ophthalmol 18:2–10CrossRefPubMed
18.
Zurück zum Zitat Taneri S, Zieske JD, Azar DT (2004) Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Surv Ophthalmol 49:576–602CrossRefPubMed Taneri S, Zieske JD, Azar DT (2004) Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Surv Ophthalmol 49:576–602CrossRefPubMed
19.
Zurück zum Zitat Katsanevaki VJ, Kalyvianaki MI, Kavroulaki DS, Pallikaris IG (2007) One-year clinical results after epi-LASIK for myopia. Ophthalmology 114:1111–1117CrossRefPubMed Katsanevaki VJ, Kalyvianaki MI, Kavroulaki DS, Pallikaris IG (2007) One-year clinical results after epi-LASIK for myopia. Ophthalmology 114:1111–1117CrossRefPubMed
20.
Zurück zum Zitat Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, Markomanolakis M, Yoo SH (2007) Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 33:1982–1984CrossRefPubMed Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, Markomanolakis M, Yoo SH (2007) Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 33:1982–1984CrossRefPubMed
21.
Zurück zum Zitat Mazzotta C, Balestrazzi A, Baiocchi S, Traversi C, Caporossi A (2007) Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation. Clin Exp Ophthalmol 35:580–582CrossRefPubMed Mazzotta C, Balestrazzi A, Baiocchi S, Traversi C, Caporossi A (2007) Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation. Clin Exp Ophthalmol 35:580–582CrossRefPubMed
22.
Zurück zum Zitat Garcia-Delpech S, Diaz-Llopis M, Udaondo P, Salom D (2010) Fusarium keratitis 3 weeks after healed corneal cross-linking. J Refract Surg 26:994–995CrossRefPubMed Garcia-Delpech S, Diaz-Llopis M, Udaondo P, Salom D (2010) Fusarium keratitis 3 weeks after healed corneal cross-linking. J Refract Surg 26:994–995CrossRefPubMed
23.
Zurück zum Zitat Sharma N, Maharana P, Singh G, Titiyal JS (2010) Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg 36:517–520CrossRefPubMed Sharma N, Maharana P, Singh G, Titiyal JS (2010) Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg 36:517–520CrossRefPubMed
24.
Zurück zum Zitat Litwak S, Zadok D, Garcia-de Quevedo V, Robledo N, Chayet AS (2002) Laser-assisted subepithelial keratectomy versus photorefractive keratectomy for the correction of myopia. A prospective comparative study. J Cataract Refract Surg 28:1330–1333CrossRefPubMed Litwak S, Zadok D, Garcia-de Quevedo V, Robledo N, Chayet AS (2002) Laser-assisted subepithelial keratectomy versus photorefractive keratectomy for the correction of myopia. A prospective comparative study. J Cataract Refract Surg 28:1330–1333CrossRefPubMed
25.
Zurück zum Zitat Chen CC, Chang JH, Lee JB, Javier J, Azar DT (2002) Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Investig Ophthalmol Vis Sci 43:2593–2602 Chen CC, Chang JH, Lee JB, Javier J, Azar DT (2002) Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Investig Ophthalmol Vis Sci 43:2593–2602
26.
Zurück zum Zitat Lee HK, Lee KS, Kim JK, Kim HC, Seo KR, Kim EK (2005) Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser. Am J Ophthalmol 139:56–63CrossRefPubMed Lee HK, Lee KS, Kim JK, Kim HC, Seo KR, Kim EK (2005) Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser. Am J Ophthalmol 139:56–63CrossRefPubMed
Metadaten
Titel
Comparison of pain after subepithelial versus conventional accelerated corneal collagen cross-linking for keratoconus
verfasst von
Shaowei Li
Huatao Xie
Man Xu
Meiyan Li
Chang Liu
Jingliang He
Tian Han
Xingtao Zhou
Publikationsdatum
07.05.2018
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-018-0935-x

Neu im Fachgebiet Augenheilkunde

Zirkulierende Tumorzellen bei uvealem Melanom

Die Erstbeschreibung von Tumorzellen in der Blutbahn erfolgte 1869 durch Thomas Ashworth. Dieser beschrieb in der Blutprobe eines metastasierten Krebskranken „cells identical with those of the cancer itself“ und postulierte, dass diese „may tend …

Elektrophysiologie in der Augenheilkunde

Mit elektrophysiologischen Untersuchungen kann man in der Augenheilkunde die Funktionalität der Neurone der Sehbahn untersuchen. Weil elektrophysiologische Ableitungen von der subjektiven Wahrnehmung und Antwort des Patienten unabhängig sind …

„Liquid biopsy“ bei Retinoblastom

Die „liquid biopsy“ spielt eine zunehmend wichtige Rolle bei der Diagnose und Behandlung des Retinoblastoms. Die Möglichkeit der sicheren und unkomplizierten Entnahme und Untersuchung von Kammerwasser aus der Vorderkammer trägt wesentlich zur …

Die „onkologische Spur“: zirkulierende Tumor-DNA beim Aderhautmelanom

In Körperflüssigkeiten wurde zirkulierende Desoxyribonukleinsäure (DNA) bereits vor mehr als 75 Jahren beschrieben [ 19 ]. Aber erst durch die eindrucksvolle technische Weiterentwicklung im Bereich der Nukleinsäureanalyse in den letzten Jahren ist …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.